Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

1
Player Avatar alcear (38.17) Submitted: 4/29/2011 12:18:28 PM : Outperform Start Price: $34.18 MRK Score: +12.86

rotation into healthcare

Report this Post Reply

Featured Broker Partners


Advertisement